EGFR and breast cancer: Collectively, these data suggest that Axl intrinsically activates an invasive/metastatic pathway in epithelial cells, consistent with previous reports that demonstrated the essential role of Axl in EMT transition in breast cancer metastasis [54] and also in EGFR-targeted drug-resistant tumors [55].